[Federal Register Volume 67, Number 120 (Friday, June 21, 2002)]
[Notices]
[Page 42276]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-15765]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel. Betacellulin Gene 
Varient and Insulin Secretion.
    Date: July 2, 2002.
    Time: 5 p.m. to 6:15 p.m.
    Agenda: To review and evaluate grant applications.
    Place: 2 Democracy Plaza, 6707 Democracy Blvd, Bethesda, MD 
20892 (Telephone Conference Call)
    Contact Person: Maria E. Davila-Bloom, PHD, Scientific Review 
Administrator, Review Branch, DEA, NIDDK, Room 746, 6707 Democracy 
Boulevard, National Institutes of Health, Bethesda, MD 20892, 301-
594-7637, [email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: June 14, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-15765 Filed 6-20-02; 8:45 am]
BILLING CODE 4140-01-M